Overview

Tong-Xie-Yao-Fang Granules for Diarrhea-predominant Irritable Bowel Syndrome

Status:
Completed
Trial end date:
2017-03-01
Target enrollment:
0
Participant gender:
All
Summary
The purpose of this study is to test the efficacy and safety of a traditional Chinese medication Tong-Xie-Yao-Fang for patients with diarrhea-predominant irritable bowel Syndrome (IBS-D).
Phase:
Phase 2/Phase 3
Accepts Healthy Volunteers?
No
Details
Lead Sponsor:
Chengdu University of Traditional Chinese Medicine
Criteria
Inclusion Criteria:

- Being diagnosed as IBS according to the Rome III criteria;

- Diarrhea was present for at least 75% of the time;

- With a TCM differentiation as "liver stagnation and spleen defficiency"

- Had a colonoscopy within a year to rule out other bowel diseases.

Exclusion Criteria:

- Organic gastrointestinal disease, such as colorectal cancer, inflammatory bowel
disease, advanced colonic polyp;

- Had gastrointestinal surgery within a year;

- Used durgs that affect gastrointestinal motility;

- Had psychological disorder;

- Serious disease in other system, which may bias the outcome measures.